Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
Clinical trial NCT03245385 · TERMINATED
Trial details
- NCT number
- NCT03245385
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2018-02-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.